MVCAX | RSVAX | MVCAX / RSVAX | |
Total Expense Ratio | 0.99 | 1.30 | 76% |
Annual Report Gross Expense Ratio | 1.00 | 1.33 | 75% |
Fund Existence | 24 years | 32 years | - |
Gain YTD | 3.325 | 0.682 | 487% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1B | 255M | 6,706% |
Annual Yield % from dividends | 0.86 | 0.37 | 230% |
Returns for 1 year | -3.52 | -5.62 | 63% |
Returns for 3 years | 6.81 | -3.08 | -222% |
Returns for 5 years | 47.65 | 22.76 | 209% |
Returns for 10 years | 63.09 | -23.21 | -272% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PQJL | 27.66 | 0.25 | +0.91% |
PGIM NASDAQ-100 BUFFER 12 ETF - JULY | |||
HELX | 29.58 | 0.21 | +0.73% |
Franklin Genomic Advancements ETF | |||
IDOG | 36.00 | 0.23 | +0.64% |
ALPS International Sector Div Dogs ETF | |||
FAAR | 28.92 | 0.02 | +0.06% |
First Trust Alt Abs Ret Strat ETF | |||
SECT | 60.05 | -0.22 | -0.37% |
Main Sector Rotation ETF |